| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2023 |
4
| Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 03/16/2023 |
4
| Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 1,106 shares
@ $31.5021, valued at
$34.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Hambleton Julie (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 29,497 options to buy
@ $17.11, valued at
$504.7k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2021 |
4
| Hambleton Julie (Director) has filed a Form 4 on Erasca, Inc.|
Txns:
| Bought 6,000 shares
@ $16, valued at
$96k
|
|
| 07/15/2021 |
3
| Hambleton Julie (Director) has filed a Form 3 on Erasca, Inc. |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 14,668 options to buy
@ $38.03, valued at
$557.8k
|
|
| 05/22/2020 |
3
| Hambleton Julie (Director) has filed a Form 3 on SpringWorks Therapeutics, Inc. |
| 02/25/2020 |
4
| Hambleton Julie (SVP, Chief Medical Officer) has filed a Form 4 on IDEAYA Biosciences, Inc.|
Txns:
| Granted 62,500 options to buy
@ $6.92, valued at
$432.5k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/22/2019 |
3
| Hambleton Julie (SVP, Chief Medical Officer) has filed a Form 3 on IDEAYA Biosciences, Inc. |